EARLY ADMINISTRATION OF ANAKINRA, CORTICOSTERIODS, AND REMDESIVIR FOR THE MANAGEMENT OF A PATIENT WITH CARDIOGENIC SHOCK AND CARDIAC TAMPONADE FROM SUSPECTED COVID-INDUCED FULMINANT MYOCARDITIS

Publication/Presentation Date

4-2024

Volume

83

Issue

13

First Page

3717

Last Page

3717

Disciplines

Medicine and Health Sciences

Department(s)

Cardiology Division

Document Type

Article

Share

COinS